{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T12:48:32Z","timestamp":1725540512706},"publisher-location":"Totowa, NJ","reference-count":10,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781607614586"},{"type":"electronic","value":"9781607614593"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-60761-459-3_33","type":"book-chapter","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T17:05:30Z","timestamp":1258131930000},"page":"351-358","source":"Crossref","is-referenced-by-count":2,"title":["Gas Chromatography-Mass Spectrometry Method for the Determination of Methadone and 2-Ethylidene-1,5-Dimethyl-3, 3-Diphenylpyrrolidine (EDDP)"],"prefix":"10.1007","author":[{"given":"Christine L.H.","family":"Snozek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew W.","family":"Bjergum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loralie J.","family":"Langman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,30]]},"reference":[{"key":"33_CR1","unstructured":"Gutstein, H.B. and Akil, H. (2001) Opioid analgesics. In: Hardman, J., Limbird, L. and Gilman, A. (eds.). Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics, Vol. 10th ed. New York, NY: McGraw-Hill, 569\u2013619"},{"key":"33_CR2","unstructured":"DOLOPHINE\u00ae HYDROCHLORIDE (Methadone hydrochloride tablets, USP), (2006) Package Insert. Columbus, OH: Roxane Laboratories, Inc."},{"key":"33_CR3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"C.B. Eap","year":"2002","unstructured":"Eap, C.B., Buclin, T. and Baumann, P. (2002) Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet, 41, 1153\u201393.","journal-title":"Clin Pharmacokinet"},{"key":"33_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","volume":"50","author":"A. Ferrari","year":"2004","unstructured":"Ferrari, A., Coccia, C.P., Bertolini, A. and Sternieri, E. (2004) Methadone \u2013 metabolism, pharmacokinetics and interactions. Pharmacol Res, 50, 551\u20139.","journal-title":"Pharmacol Res"},{"key":"33_CR5","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"R.C. Baselt","year":"2005","unstructured":"Baselt, R.C. (2005) Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Chemical Toxicology Institute, Foster City, CA.","edition":"7"},{"key":"33_CR6","unstructured":"Kerrigan, S. and Goldberger, B.A. (2003) Opioids. In: Levine, B., ed. Principles of Forensic Toxicology, Vol. 2nd ed. Washington DC: AACC Press, 187\u2013205."},{"key":"33_CR7","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"R.C. Baselt","year":"2004","unstructured":"Baselt, R.C. (2004) Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Biomedical Publications, Foster City, CA.","edition":"7"},{"key":"33_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jat\/23.2.81","volume":"23","author":"S. George","year":"1999","unstructured":"George, S. and Braithwaite, R.A. (1999) A pilot study to determine the usefulness of the urinary excretion of methadone and its primary metabolite (EDDP) as potential markers of compliance in methadone detoxification programs. J Anal Toxicol, 23, 81\u20135.","journal-title":"J Anal Toxicol"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jat\/23.7.615","volume":"23","author":"F.R. Galloway","year":"1999","unstructured":"Galloway, F.R. and Bellet, N.F. (1999) Methadone conversion to EDDP during GC-MS analysis of urine samples. J Anal Toxicol, 23, 615\u20139.","journal-title":"J Anal Toxicol"},{"issue":"Pt 3","key":"33_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1258\/0004563001899249","volume":"37","author":"S. George","year":"2000","unstructured":"George, S., Gill, L. and Braithwaite, R.A. (2000) Simple high-performance liquid chromatographic method to monitor vigabatrin, and preliminary review of concentrations determined in epileptic patients. Ann Clin Biochem, 37(Pt 3), 338\u201342.","journal-title":"Ann Clin Biochem"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60761-459-3_33.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T22:10:57Z","timestamp":1619907057000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60761-459-3_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,30]]},"ISBN":["9781607614586","9781607614593"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-60761-459-3_33","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2009,10,30]]}}}